Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001104659-25-075791

Chief Medical Officer acquired 70,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Deliargyris Efthymios Chief Medical Officer 2025-08-08 Grant or award +70,000 473,025 D
Derivatives
Deliargyris Efthymios Chief Medical Officer 2025-08-08 Grant or award · Stock Option (Right to Buy) +95,000 95,000 D
Loading xslF345X05/tm2522995-3_4seq1.xml…